Moderna, the FDA, and Vinay Prasad
Moderna, the FDA, and Vinay Prasad is drawing significant interest across the industry.
STAT reporters discuss the FDA's refusal to review Moderna's mRNA flu vaccine and the implications for the biotech industry and innovation.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Ukraine’s startups keep building
- Forget pinkwashing on International Women’s Day - this is what Irish women need
- Nepalese PM Karki urges people to actively participate in general elections
- ‘Ticked almost all the boxes’: Suryakumar Yadav sends Super 8s warning after dominant run in T20 World Cup
Source: Original →